Compass Pathways
Clinical trials sponsored by Compass Pathways, explained in plain language.
-
Magic mushroom compound takes on tough depression in major trial
Symptom relief OngoingThis study tests a single dose of COMP360, a psilocybin-based drug, in 255 adults with treatment-resistant depression. Participants receive either the drug or a placebo, and researchers measure changes in depression severity and daily functioning over time. The goal is to see if …
Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated May 26, 2026 09:13 UTC
-
Magic mushroom compound shows promise for stubborn depression in major trial
Symptom relief OngoingThis study tests a drug called COMP360, made from a psychedelic compound, in people with depression that hasn't improved with other treatments. About 572 adults will receive either a low or higher dose to see if it safely reduces depression symptoms and improves daily functioning…
Phase: PHASE3 • Sponsor: COMPASS Pathways • Aim: Symptom relief
Last updated May 26, 2026 09:03 UTC